32Diversification of specific DNA segments typically involve in vitro generation of large sequence 33 libraries and their introduction in cells for selection. Alternative in vivo mutagenesis systems on 34 cells often show deleterious offsite mutations and restricted capabilities. To overcome these 35 limitations, we have developed an in vivo platform to diversify specific DNA segments based on 36 protein fusions between various base deaminases (BD) and the T7 RNA polymerase (T7RNAP) 37 that recognizes a cognate promoter oriented towards the target sequence. The transcriptional 38 elongation of these fusions generates transitions C to T or A to G on both DNA strands and in 39 long DNA segments. To delimit the boundaries of the diversified DNA, the catalytically dead 40 Cas9 (dCas9) is tethered with custom-designed crRNAs as a "roadblock" for BD-T7RNAP 41 elongation. While the efficiency of this platform is demonstrated in E. coli, the system can be 42 adapted to a variety of bacterial and eukaryotic hosts. 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58Directed evolution enables the selection of protein variants with improved properties as 59 therapeutics and biocatalysts 1, 2, 3 . The generation of genetic variability followed by a screening 60 process are the essential steps of directed evolution 4, 5 . In vitro mutagenesis techniques (e.g.,
61error-prone PCR) can quickly produce large number of variants of the target gene but their 62 selection requires, in most cases, cloning and transformation into a host cell for expression (e.g.,
63E. coli). These steps are time-consuming and labor-intensive, especially when iterative cycles 64 of mutagenesis and selection are needed. Cell-free selection methods are also feasible 6 , but 65 they are technically demanding and functional expression of complex proteins (e.g. membrane 66 proteins, multimeric enzymes) is often difficult to achieve. Hence, in vivo mutagenesis systems 67 are preferred because the generation of genetic variants, their expression and selection can 68 done in a continuous process, which accellerates directed evolution 5, 7 .
70Long-established in vivo mutagenesis methods (e.g., chemical mutagens, radiations) do not 71 target specific genes and are deleterious for the host cell due to accumulation of random 72 mutations in the genome 8 . Similarly, "mutator" host strains do not allow the concentration of the 73 mutagenic activity on the target gene, inducing the accumulation of unwanted mutations in the 74 host genome 9, 10, 11, 12 . A few in vivo mutagenesis systems with targeted specificity have been 75 reported for E. coli and yeast cells, which are the preferred hosts for cloning and expression of 76 gene libraries 5 . For example, an error-prone variant of E. coli DNA polymersase I enables the 77 mutagenesis of cloned genes in ColE1 plasmids, although it concentrates the mutations close 78 to the origin of replication 13 . A different approach involves the transformation of E. coli with 79 mutant oligonucleotide libraries, targeting one or multip...